Register  for the main conference & book your hotel through the congress registrar by August 1st, to enter to win 1 of 3 iPads!  

Breaking News

Hand-held device on trial for migraine sufferers
March 4, 2010 - A new hand-held device that delivers a magnetic pulse to the back of the head could become an alternative to drug treatment for people with migraines. The findings of a 200-person study, published in The Lancet Neurology, showed that the single-pulse transcranial magnetic stimulation (sTMS) from the device is a promising acute treatment for some patients with migraine with aura.  (BBC News)

Imaging Advances Promote Growth of DBS
March 4, 2010 - Neurosurgeons are developing new tools to improve the implantation process. (Neurotech Business Report)

Commentary: Focus on Epilepsy
March 4, 2010 - Editor James Cavuoto comments on the market opportunity for neurosensing systems and neurosurgical tools created by neurosurgical treatment for epilepsy. (Neurotech Business Report)

New MRI May Lead to Better Brain Pictures
March 1, 2010 - Researchers are reporting that they've developed a new kind of MRI sensor that can detect the neurotransmitter known as dopamine, potentially allowing doctors to get better views inside the brain.  (Yahoo News: HealthDay News)

Study results send shares of Uroplasty climbing
March 1, 2010 - The results from a 220-patient clinical trial using the UrgentPC device to stimulate the tibial nerve in the ankle to treat urge incontinence and frequency urination are  published in the April issue of the Journal of Urology. In the study, 58% of the patients  experienced "moderately or markedly improved" symptoms, compared with 22% of the patients who received a simulated procedure. (Star Tribune)

Electric stimulation may help stroke victims swallow
February 24, 2010 - Tiny electric shocks to the throat may help stroke victims overcome disabling swallowing difficulties, a small British study suggests. (Reuters Health)

A Brain Implant that Uses Light - A novel optical device could ultimately be used to treat neurological disease
February 24, 2010 - Researchers are developing a prototype neural implant that uses light to alter the behavior of neurons in the brain. The device is based on the emerging science of optogenetic neuromodulation, in which specific brain cells are genetically engineered to respond to light. (Technology Review)

 For more neuromodulation news, please visit the Newsroom.

Medical Professionals can learn about the various treatments and benefits of neuromodulation and clinic contacts. Once your preliminary questions have been answered, please use the Contact Us facility to find out more and to discuss specific requirements. Others may simply wish to join the INS and one of its related chapter societies, please use Membership Application.

If you are not a medical professional and you are searching for information about neuromodulation and how these types of treatment could benefit a specific condition, you may find About Neuromodulation and FAQs particularly helpful.

The International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation - the alteration of nerve activity through the delivery of electrical stimulation or chemical agents to targeted sites of the body. Founded in 1989 and based in San Francisco, CA, the INS educates and promotes the field through meetings, its quarterly, peer-reviewed journal Neuromodulation: Technology at the Neural Interface and chapter websites.

Neuromodulation: Technology at the Neural Interface contains articles of the highest scientific caliber. The journal's sole purpose is to advance the basic and clinical science of the field of neuromodulation. It publishes scientific works, scientific reviews, and abstracts of papers accepted for review at national and international congresses.